We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$4.82B
AUM Growth
+$522M
Cap. Flow
+$73.4M
Cap. Flow %
1.52%
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$48.8M
2
CMCSA icon
Comcast
CMCSA
+$46.9M
3
AVY icon
Avery Dennison
AVY
+$38.5M
4
MIDD icon
Middleby
MIDD
+$33M
5
LKQ icon
LKQ Corp
LKQ
+$32.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.65%
2 Financials 14.81%
3 Industrials 14.31%
4 Technology 11.57%
5 Energy 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBIS
101
Nebius Group N.V.
NBIS
$59.4B
$7.09M 0.15%
194,603
+166,082
+582% +$5.46M
TRGP icon
102
Targa Resources
TRGP
$62B
$6.87M 0.14%
94,098
-41,747
-31% -$2.88M
XOM icon
103
ExxonMobil
XOM
$643B
$6.86M 0.14%
79,705
-601
-0.7% -$54.2K
SHW icon
104
Sherwin-Williams
SHW
$83.8B
$6.67M 0.14%
109,845
-656,034
-86% -$38.5M
IBM icon
105
IBM
IBM
$225B
$6.57M 0.14%
37,093
-1,274
-3% -$232K
BIIB icon
106
Biogen
BIIB
$32.7B
$6.56M 0.14%
27,265
+14,440
+113% +$3.23M
GEL icon
107
Genesis Energy
GEL
$2B
$6.53M 0.14%
130,420
+3,780
+3% +$190K
GRFS
108
Grifois
GRFS
$5.32B
$6.5M 0.14%
429,620
+111,884
+35% +$1.74M
WFM
109
DELISTED
Whole Foods Market Inc
WFM
$6.45M 0.13%
110,199
-93,599
-46% -$5.17M
ARMH
110
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$6.34M 0.13%
131,700
-101,997
-44% -$4.31M
CBI
111
DELISTED
Chicago Bridge & Iron Nv
CBI
$5.75M 0.12%
84,806
+29,591
+54% +$1.83M
JNJ icon
112
Johnson & Johnson
JNJ
$640B
$5.35M 0.11%
61,745
-3,737
-6% -$335K
ENB icon
113
Enbridge
ENB
$109B
$5.28M 0.11%
126,381
-81,982
-39% -$3.49M
GE icon
114
GE Aerospace
GE
$356B
$5.05M 0.1%
44,146
+2,958
+7% +$339K
GLD icon
115
SPDR Gold Trust
GLD
$154B
$4.94M 0.1%
38,561
-626
-2% -$80.4K
CNI icon
116
Canadian National Railway
CNI
$76.5B
$4.72M 0.1%
93,072
+13,294
+17% +$656K
MCD icon
117
McDonald's
MCD
$184B
$4.71M 0.1%
48,995
-197,215
-80% -$19.3M
BRK.B icon
118
Berkshire Hathaway Class B
BRK.B
$1.08T
$4.67M 0.1%
41,159
+7,364
+22% +$850K
PG icon
119
Procter & Gamble
PG
$333B
$4.46M 0.09%
58,976
-3,489
-6% -$278K
NGLS
120
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
$4.37M 0.09%
84,800
+3,720
+5% +$187K
JPM icon
121
JPMorgan Chase
JPM
$942B
$4.23M 0.09%
81,866
+2,427
+3% +$130K
BIP icon
122
Brookfield Infrastructure Partners
BIP
$17.9B
$4.2M 0.09%
278,634
-936,288
-77% -$13.6M
EVTC icon
123
Evertec
EVTC
$1.76B
$4.14M 0.09%
186,615
+58,244
+45% +$1.39M
CSTE icon
124
Caesarstone
CSTE
$111M
$4.07M 0.08%
89,111
+25,372
+40% +$960K
MWIV
125
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$4.04M 0.08%
27,015
+3,265
+14% +$462K

Similar funds

Geneva Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
  • Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
  • Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
  • Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
  • Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
  • Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
  • Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.

Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.